VanEck Associates’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

VanEck Associates’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,040	Closed	-$990K	–	1433
2024 Q1	$990K	Sell	3,040 -95	-3%	-$23.3K	﹤0.01%	985
2023 Q4	$597K	Sell	3,135 -532	-15%	-$101K	﹤0.01%	1028
2023 Q3	$730K	Sell	3,667 -1,086	-23%	-$257K	﹤0.01%	975
2023 Q2	$1.36M	Sell	4,753 -5,069	-52%	-$1.41M	﹤0.01%	797
2023 Q1	$2.13M	Buy	9,822 +5,357	+120%	+$1.04M	﹤0.01%	696
2022 Q4	$918K	Buy	4,465 +1,100	+33%	+$278K	﹤0.01%	824
2022 Q3	$936K	Buy	+3,365	New	+$856K	﹤0.01%	788

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

VanEck Associates's SWAV Position: Q2 2024 in Review

VanEck Associates sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 3,040 shares — an estimated $990K sold.

VanEck Associates first reported a position in SWAV in Q3 2022 and held it in 7 quarters. The position peaked at $2.13M in Q1 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

VanEck Associates reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
VanEck Associates sold 3,040 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $990K.
VanEck Associates first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
VanEck Associates's Shockwave Medical, Inc. Common Stock position peaked at $2.13M in Q1 2023.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on VanEck Associates's 13F filing for Q2 2024, filed 31 Jul 2024.